Haynes Lia M, Miao Congrong, Harcourt Jennifer L, Montgomery Joel M, Le Mai Quynh, Dryga Sergey A, Kamrud Kurt I, Rivers Bryan, Babcock Gregory J, Oliver Jennifer Betts, Comer James A, Reynolds Mary, Uyeki Timothy M, Bausch Daniel, Ksiazek Thomas, Thomas William, Alterson Harold, Smith Jonathan, Ambrosino Donna M, Anderson Larry J
National Centers for Immunization and Respiratory Diseases, Division of Viral Diseases, Respiratory and Gastroenteritis Viruses Branch, Centers for Disease Control and Prevention, 1600 Clifton Rd. NE, Mailstop G-18, Atlanta, GA 30333.
Clin Vaccine Immunol. 2007 Mar;14(3):331-3. doi: 10.1128/CVI.00351-06. Epub 2007 Jan 17.
Recombinant severe acute respiratory syndrome (SARS) nucleocapsid and spike protein-based immunoglobulin G immunoassays were developed and evaluated. Our assays demonstrated high sensitivity and specificity to the SARS coronavirus in sera collected from patients as late as 2 years postonset of symptoms. These assays will be useful not only for routine SARS coronavirus diagnostics but also for epidemiological and antibody kinetic studies.
研发并评估了基于重组严重急性呼吸综合征(SARS)核衣壳蛋白和刺突蛋白的免疫球蛋白G免疫测定法。我们的测定法对症状出现后长达2年的患者血清中的SARS冠状病毒显示出高灵敏度和特异性。这些测定法不仅将有助于常规SARS冠状病毒诊断,还将有助于流行病学和抗体动力学研究。